Hospital
Okaloosa Hospital INC
Okaloosa Hospital INC was paid $2.55M by Medicaid between Jan 2018 and Dec 2024, across 84 billing codes. Its largest line is 99283, emergency room visit (moderate) — 34% of everything it billed.
33Billing provider infoOKALOOSA HOSPITAL INC
NICEVILLE, FL 32578
NICEVILLE, FL 32578
33aNPI1891732988assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.55M
24GClaims121,693
24DCodes billed84
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#110 of 163
Median peer was paid$4.77M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,356 | $122K | |
| 2019 | 22,559 | $372K | |
| 2020 | 18,684 | $208K | |
| 2021 | 24,374 | $487K | |
| 2022 | 23,811 | $638K | |
| 2023 | 14,993 | $459K | |
| 2024incomplete | 6,916 | $266K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 34% | 11,600 | 10,490 | $880K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 7,369 | 6,264 | $458K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7.5% | 1,949 | 354 | $192K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.1% | 937 | 811 | $155K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.9% | 1,249 | 993 | $124K |
| 80053 | Comprehensive metabolic panel | 4.5% | 7,405 | 5,801 | $116K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.7% | 1,203 | 1,136 | $95K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.0% | 526 | 432 | $77K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.5% | 1,540 | 1,205 | $64K |
| J7050 | Infusion, normal saline solution, 250 cc | 2.0% | 1,284 | 817 | $50K |
| 71046 | Radiologic examination, chest; 2 views | 1.2% | 3,025 | 2,682 | $32K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 1,936 | 1,533 | $28K |
72 more codes
| A9270 | Non-covered item or service | <1% | 3,046 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 379 | $25K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 192 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,244 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,842 | $15K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,640 | $13K |
| 81001 | <1% | 3,701 | $11K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 48 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,765 | $10K |
| 85027 | <1% | 9,778 | $9K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 408 | $9K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,374 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,154 | $8K |
| 86756 | <1% | 291 | $7K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 358 | $7K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,052 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,022 | $7K |
| 81003 | <1% | 1,316 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 985 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 301 | $5K |
| 87040 | <1% | 1,313 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,891 | $5K |
| 85610 | <1% | 1,514 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,604 | $4K |
| 84484 | <1% | 2,474 | $4K | |
| 85730 | <1% | 1,354 | $4K | |
| 83735 | <1% | 4,117 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 815 | $4K |
| 73630 | <1% | 87 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,386 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,266 | $2K |
| 82550 | <1% | 1,578 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 15 | $1K |
| 83690 | <1% | 3,689 | $1K | |
| 81025 | <1% | 1,078 | $1K | |
| 73610 | <1% | 32 | $1K | |
| 83605 | <1% | 671 | $873.56 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 820 | $867.75 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,309 | $819.84 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,464 | $791.96 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 919 | $775.65 |
| 87077 | <1% | 28 | $765.85 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 979 | $729.01 |
| 87400 | <1% | 740 | $646.93 | |
| G0378 | Hospital observation service, per hour | <1% | 105 | $587.14 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 249 | $500.38 |
| 83880 | <1% | 587 | $487.81 | |
| 85378 | <1% | 275 | $411.95 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $389.20 |
| 84703 | <1% | 1,234 | $362.24 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 40 | $141.64 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 18 | $130.84 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $113.40 |
| 80061 | Lipid panel | <1% | 108 | $63.37 |
| 87807 | <1% | 36 | $52.80 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $43.55 |
| 87070 | <1% | 17 | $39.00 | |
| 80076 | <1% | 134 | $36.75 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 69 | $30.85 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 100 | $29.55 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $18.41 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 13 | $0.00 |
| 82553 | 0% | 24 | $0.00 | |
| 96376 | 0% | 12 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 12 | $0.00 |
| 87088 | 0% | 45 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 84 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 140 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,078 | $0.00 |
| 87186 | 0% | 92 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 68 | $0.00 |
| 84439 | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAY, MARK (CFO)
| Provider | Location | Paid |
|---|---|---|
| Generations Obstetrics & Gynecology | Springboro, OH | $199K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.